ATH alterity therapeutics limited

Verbatim patient-reported outcomes and trails making test B (TMT-B) performance in the REACH2HD tria, page-3

  1. 1,523 Posts.
    lightbulb Created with Sketch. 98

    I agree, to read Ira Shoulson being so pleased at these recent findings reassures me he will fight heaven and earth to have it realesed from the PCH and made available to the HD community ASAP ( whether through phase 3 trials or accelerated approval).

    It would be nice to hear from someone in the HD community what their thoughts are on these findings and what it means to them.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
-0.001(8.33%)
Mkt cap ! $100.4M
Open High Low Value Volume
1.2¢ 1.2¢ 1.1¢ $84.30K 7.324M

Buyers (Bids)

No. Vol. Price($)
23 28529451 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 1166855 4
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.